This opportunity is no longer accepting applications.
grant PAR-25-108

Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)

The National Cancer Institute is offering grants for research using microorganisms like bacteria, bacteriophages, or non-oncolytic viruses to explore their interactions with tumors and the immune system, aiming to enhance cancer treatment, imaging, or diagnosis. The focus is on early exploratory studies that test new ideas using microorganisms as anti-tumor agents or for activating tumor immun…

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactio…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute

Dates

Opportunity Released: November 8, 2024
Open for Submission: November 12, 2024
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.